Healthcare -
Biotechnology - NASDAQ - US
$ 2.72
-1.45 %
$ 189 M
Market Cap
-0.87
P/E
IKT - CHANGE IN WORKING CAPITAL
Change in Working Capital IKT - Inhibikase Therapeutics, Inc.
235 K
LAST VALUE
46.05%
2 YEAR CAGR
-31.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR